Target intelligence / Profile preview

Vacuolar H+-ATPase c-ring (V-ATPase c-ring) (V-ATPase c-ring)

Target
V-ATPase c-ring
Molecular classification
Transporter, Enzyme, Proton pump
01

Overview

The Vacuolar H+-ATPase (V-ATPase) c-ring is a membrane-embedded rotary component of the V-ATPase holoenzyme, a multi-subunit proton pump responsible for acidifying intracellular compartments and the extracellular environment (Forgac, 2007; Nishi and Forgac, 2002). Composed of multiple proteolipid subunits (primarily subunit c, encoded by ATP6V0C), the c-ring rotates relative to the 'a' subunit to translocate protons across the lipid bilayer, driven by ATP hydrolysis in the cytosolic V1 domain (Inoue et al., 2005). This acidification is vital for lysosomal function, protein sorting, and the entry of various pathogens such as influenza and Ebola viruses (Marshansky et al., 2008). In cancer, the c-ring is frequently upregulated and localized to the plasma membrane, where it acidifies the tumor microenvironment to facilitate extracellular matrix degradation, metastasis, and drug resistance (Sennoune et al., 2004; Lu and Qin, 2011). It also plays a pivotal role in bone resorption by osteoclasts, making it a target for treating osteoporosis (Gordon & Drum, 1994). While potent inhibitors like bafilomycins and archazolids target the c-ring to block proton transport, their clinical utility is currently limited by systemic toxicity due to the essential housekeeping roles of V-ATPases in all eukaryotic cells (Huss and Wieczorek, 2009).

Other names
V-ATPase proteolipid ringV0 c-ringVacuolar proton pump c-ringATP6V0C ring16 kDa proteolipid ring
02

Mechanism of action

Inhibition of the V0 domain rotation and blocking of the proton-conducting pore within the proteolipid c-ring, thereby preventing ATP-driven proton translocation across membranes (Forgac, 2007; Huss and Wieczorek, 2009).

03

Biological functions

Organelle acidificationProton transportMembrane traffickingProtein degradationNutrient sensingBone resorptionUrinary acidification
04

Disease associations

CancerOsteoporosisViral infectionNeurodegenerative diseaseRenal tubular acidosis
05

Safety considerations

Systemic toxicity due to ubiquitous expressionPotential for lysosomal storage disordersRenal dysfunctionImpaired autophagy and protein clearanceNarrow therapeutic window
06

Interacting drugs

Bafilomycin A1

8 more in the full profile.

07

Biomarkers

ATP6V0C expression levelsLysosomal pHC-terminal telopeptide of type I collagen (CTx-I)N-terminal telopeptide of type I collagen (NTx-I)

Beyond the preview

Go deeper on Vacuolar H+-ATPase c-ring (V-ATPase c-ring) (V-ATPase c-ring).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuolar H+-ATPase c-ring (V-ATPase c-ring) (V-ATPase c-ring).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call